First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review-MedSci.cn

First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review

Sidrak, MMA; De Feo, MS; Frantellizzi, V; Marongiu, A; Caponnetto, S; Filippi, L; Nuvoli, S; Spanu, A; Schillaci, O; De Vincentis, G

Frantellizzi, V (通讯作者)，Sapienza Univ Rome, Dept Radiol Sci Oncol & Anat Pathol, Nucl Med, Rome, Italy.;Frantellizzi, V (通讯作者)，Sapienza Univ Rome, Dept Radiol Sci Oncol & Anat Pathol, Nucl Med, Viale Regina Elena 324, I-00161 Rome, Italy.

Abstract

Introduction: Lung cancer (LC) is a leading cause of death among men and women, with non-small cell LC (NSCLC) accounting for a substantial portion of......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review

科室

工具

服务